Nader Pourhassan

Nader Pourhassan is a declared insider of CytoDyn Inc. (chief executive), with filings sourced from SEC (Form 4). The record holds 30 filings, for trades running from 11 October 2013 to 6 August 2021.

On the open market, the record shows 1 purchase worth €9,085 and 3 sales worth €14.4M. Taken together, the sales exceed the purchases by €14.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 13 share grants and 11 option exercises.

On 10 August 2021 came the latest disclosure, a share grant in CytoDyn Inc. The last insider purchase was made public on 21 October 2016, 3,655 days ago. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.